Sage Journals: Discover world-class research

Open access

Review article

First published 2019

Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria

Robert M. Stern, Nathan T. Connell

Therapeutic Advances in Hematology

Retricted access

Review article

First published 2021-3

New Therapeutic Targets and Treatment Options for Thrombotic Microangiopathy: Caplacizumab and Ravulizumab

Clement Chung

Annals of Pharmacotherapy

Open access

Research article

First published 2026-4

Safety and efficacy of ravulizumab in patients with NMOSD previously treated with rituximab: A post hoc analysis of the CHAMPION-NMOSD trial

JL Bennett, S Bhattacharyya, A Zabeti [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2020

One-year efficacy and safety of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria naïve to complement inhibitor therapy: open-label extension of a randomized study

Hubert Schrezenmeier, Austin Kulasekararaj, Lindsay Mitchell [...]

Therapeutic Advances in Hematology

Open access

Research article

First published 2025

Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb,open-label study

Miriam Freimer, Urvi Desai, Raghav Govindarajan [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2024

Complement inhibition in seropositive generalized myasthenia gravis as rescue therapy in impending and effective treatment in frequently recurring impending myasthenic crisis—a case series

Martina Menacher, Monika Ellssel, Isabelle Kwiedor [...]

Therapeutic Advances in Neurological Disorders

Open access

Review article

First published 2022

The importance of terminal complement inhibition in paroxysmal nocturnal hemoglobinuria

Austin G. Kulasekararaj, Robert A. Brodsky, Jun-ichi Nishimura [...]

Therapeutic Advances in Hematology

Open access

Research article

First published 2025

Managing transient immune complex reactions in patients with paroxysmal nocturnal hemoglobinuria: clinical observations from the COMMODORE 1 and 2 studies

Austin G. Kulasekararaj, Jun-Ichi Nishimura, Alexander Röth [...]

Therapeutic Advances in Hematology

Open access

Review article

First published 2023

Efficacy of complement inhibitors for patients with paroxysmal nocturnal hemoglobinuria: a systematic review and meta-analysis

Jiyeon Lee, Haeseon Lee, Siin Kim [...]

Therapeutic Advances in Hematology

Open access

Review article

First published 2020

A review of the treatment landscape in paroxysmal nocturnal haemoglobinuria: where are we now and where are we going?

Morag Griffin, Richard Kelly, Alexandra Pike

Therapeutic Advances in Rare Disease

Search results